Crespo-Lessmann Astrid, Mateus Eder, Torrejón Montserrat, Belda Alicia, Giner Jordi, Vidal Silvia, Sibila Oriol, Plaza Vicente
Service of Pneumology, Hospital de la Santa Ceu i Sant Pau, Institute of Sant Pau Biomedical Research (IBB Sant Pau), Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES).
Department of Immunology, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomédica Sant Pau, Barcelona, Spain.
J Asthma Allergy. 2017 Oct 12;10:269-276. doi: 10.2147/JAA.S142200. eCollection 2017.
Asthma with bronchial hypersecretion is a type of asthma that is poorly studied. Its pathogenesis is not well understood, but is probably related to innate impaired immunity, particularly with toll-like receptors (TLRs) and secretory mucins (MUC).
Cross-sectional study which included 43 non-smoking asthmatic patients without bronchiectasis, 19 with bronchiectasis, and 24 without bronchial hypersecretion. All patients underwent the following: IS, spirometry, fractional exhaled nitric oxide, prick test, total immunoglobulin E (IgE), and blood albumin. Analysis of mucins was determined by ELISA and expression of TLR2 and TLR4 by flow cytometry. The level of asthma control was determined by the Asthma Control Test (ACT) questionnaire and quality of life was assessed by the reduced version of the Asthma Quality of Life Questionnaire (mini-AQLQ).
Asthmatics with bronchial hypersecretion were significantly older (62.6 years vs 48.5 years; =0.02); had greater severity (persistent severe asthma 94.7% vs 29.2%; =0.000); a higher proportion of nasal polyposis (36.8% vs 8.3%; =0.022); less control of asthma (73.7% vs 8.3%; =0,000); a higher proportion of asthma with negative prick test (68.4% vs 16.6%; =0.001), and lower levels of IgE (113.4 IU/mL vs 448 IU/mL; =0.007), compared with asthmatics without bronchial hypersecretion. Significant differences were observed neither in the expression of TLRs 2 and 4 in inflammatory cells of IS or peripheral blood, nor in the expression of mucins between both groups.
Asthma patients with bronchial hypersecretion have more severe and uncontrolled disease, with poor quality of life as well as a non-allergic inflammatory phenotype. Within the mechanisms involving these differences, it does not appear that mucins and TLRs play an important role.
伴有支气管高分泌的哮喘是一种研究较少的哮喘类型。其发病机制尚不清楚,但可能与先天性免疫受损有关,尤其是与Toll样受体(TLRs)和分泌性粘蛋白(MUC)有关。
1)明确伴有黏液支气管高分泌的哮喘的临床和炎症表型。2)比较有和无支气管高分泌患者诱导痰(IS)中存在的粘蛋白类型。3)确定有和无支气管高分泌的哮喘患者IS和血液中TLRs的表达。
横断面研究,纳入43例无支气管扩张的非吸烟哮喘患者、19例有支气管扩张的患者和24例无支气管高分泌的患者。所有患者均接受以下检查:IS、肺功能测定、呼出一氧化氮分数、皮肤点刺试验、总免疫球蛋白E(IgE)和血白蛋白。通过酶联免疫吸附测定(ELISA)法分析粘蛋白,通过流式细胞术检测TLR2和TLR4的表达。通过哮喘控制测试(ACT)问卷确定哮喘控制水平,通过哮喘生活质量问卷简化版(mini-AQLQ)评估生活质量。
伴有支气管高分泌的哮喘患者年龄显著更大(62.6岁对48.5岁;P=0.02);病情更严重(持续性重度哮喘94.7%对29.2%;P=0.000);鼻息肉比例更高(36.8%对8.3%;P=0.022);哮喘控制更差(73.7%对8.3%;P=0.000);皮肤点刺试验阴性的哮喘比例更高(68.4%对16.6%;P=0.001),且IgE水平更低(113.4 IU/mL对448 IU/mL;P=0.007),与无支气管高分泌的哮喘患者相比。在IS或外周血炎症细胞中TLR2和TLR4的表达,以及两组之间粘蛋白的表达方面均未观察到显著差异。
伴有支气管高分泌的哮喘患者病情更严重且控制不佳,生活质量差,具有非过敏性炎症表型。在涉及这些差异的机制中,粘蛋白和TLRs似乎并未发挥重要作用。